The latest news from academia, regulators
research labs and other things of interest
Posted: November 28, 2007
RainDance Technologies Appoints McNary President and CEO
(Nanowerk News) RainDance Technologies, Inc.,
a developer of NanoReactor droplet-based microfluidic technology, today
announced the appointment of Christopher McNary as President and Chief
Executive Officer. McNary will join Jonathan Rothberg, Chairman of the
Board, in driving RainDance Technologies' vision and the upcoming
commercial launch of its Professional Laboratory System in the Life
Sciences and other related markets.
"Mr. McNary joins an outstanding leadership team that includes a
distinguished Scientific Advisory Board with three Nobel Prize recipients
and a Board of Directors with the former Presidents of Applied Biosystems
and Affymetrix, plus an experienced Partner from Mohr Davidow Ventures,"
said Rothberg. "He will assist us in attracting additional talent to
develop first-rate manufacturing and customer support capabilities and to
commercially launch our exciting new products and applications."
The RainDance Professional Laboratory System combines microdroplets and
microfluidics to enable a host of nanoscale cell-based and molecular
assays. Samples (cells, beads, DNA templates, chemical compounds) and
reactants are encapsulated in individual micron-sized droplets on
assay-specific NanoReactor chips. With each droplet being the equivalent of
a well in a microtiter plate, the Professional Laboratory System can
process and analyze 10,000 samples per second with unparalleled accuracy.
The precise manipulation of minute amounts of fluids within NanoReactor
droplets will benefit a variety of industrial and research applications,
including DNA sequencing preparation, enzyme engineering, functional cell
sorting, multiplex PCR, SNP detection, gene expression, and RNAi functional
"Our Professional Laboratory System is game-changing technology that
has attracted a tremendous level of market interest," said Darren Link,
Senior Vice President of Research and Development and RainDance
Technologies founder. "Mr. McNary's depth of expertise and proven
leadership in the commercialization of life science tools will be
instrumental in guiding our company's growth. I look forward to working
with him and our visionary Board of Directors to transform the future of
laboratory practices," he said.
Mr. McNary has more than 25 years of experience in Life Sciences and
Diagnostic markets with 14 years in senior management positions. He joins
RainDance from Thermo Fisher Scientific where he was Vice President and
General Manager. He also has served as President and CEO of early-stage
start-up companies and held executive management positions at Chiron
Diagnostics and Tecan.
"RainDance has built an impressive management team supported by a
Scientific Advisory and Board of Directors with the proven experience in
commercializing innovative technology platforms such as the Professional
Laboratory System," said McNary. "This team and platform are well
positioned to realize the full benefits of microfluidics in a variety of
markets and applications."
About RainDance Technologies, Inc.
RainDance Technologies, Inc. is a nanotechnology company devoted to
developing and commercializing the Professional Laboratory System, a
platform for droplet-based microfluidics. The Professional Laboratory
System is an integrated fluid handling system that provides precise
manipulation of minute amounts of fluids for a variety of industrial and
research applications within genomic, drug discovery, industrial enzyme
development, and molecular diagnostic markets. At the core of the system's
power are assay-specific NanoReactor chips composed of fluid handling
modules that encapsulate samples and reactants in individual micron-sized
droplets. Founded in 2004 by scientists from Harvard University, the
Medical Research Centre in Cambridge, and the ESPCI in Paris, RainDance
Technologies designed the Professional Laboratory System to be the chemical
equivalent of a personal computer. As a computer manipulates bits of
information, the system's NanoReactor technology enables the programmable
handling of cells and fluid samples for innovative assay and screening
applications. The promise of this technology has attracted an outstanding
Scientific Advisory Board, including three Nobel Prize winners (Jean-Marie
Lehn, Sir Aaron Klug, and Dr. Richard Roberts) and Sir Gregory Winter. For
more information, please visit http://www.raindancetechnologies.com.